Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium cromolyn eye drops vs placebo in allergic conjunctivitis (CAC model)
2007-004473-26Phase 2Active
- Sponsor
- Laboratoires Théa
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in allergic conjunctivitis (AC) comparing Cromabak with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint: subject self-assessed itching. Started Aug 2007; status: active.
02
Drugs
sodium cromoglicate
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on 2007-004473-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004473-26.